Recombinant Human ApoC2 (C-6His)

Description

EnkiLife provides the Recombinant Human ApoC2 (C-6His) protein,aslo know as Apolipoprotein C-II,Apolipoprotein C2,APC2 and APOC2, which features high purity, high activity, and high stability. It can be applied in scientific research, biopharmaceuticals, and other fields.Purity:Greater than 95% as determined by reducing SDS-PAGE;Endotoxin Level:<1 EU/µg as determined by LAL test.;Construction:Recombinant Human Apolipoprotein C-II is produced by our E.coli expression system and the target gene encoding Thr23-Glu101 is expressed with a 6His tag at the C-terminus.Accession:AAP35354.1. Expression Host:E.coli.Species:Human.Predicted Molecular Mass:10 KDa. Background:APOC2 activates the lipoprotein lipase in capillaries, which hydrolyzes triglycerides and thus provides free fatty acids for cells. APOC2 is component of the very low density lipoprotein (VLDL) fraction in plasma. It is also an activator of several triacylglycerol lipases. The association of APOC2 with plasma chylomicrons, VLDL, and HDL is reversible, a function of the secretion and catabolism of triglyceride-rich lipoproteins, and changes rapidly. Defects in APOC2 are the cause of hyperlipoproteinemia type 1B (HLPP1B) which characterized by hypertriglyceridemia, xanthomas, and increased risk of pancreatitis and early atherosclerosis.